Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.077 AUD | 0.00% | 0.00% | -3.75% |
Mar. 27 | Amplia Concludes Phase I Trials of Anti-Cancer Drug; Prepares for Phase II | MT |
Mar. 27 | Amplia Therapeutics Updates on Pancreatic Cancer Trial; Phase-Two Recruitment Ongoing; Shares Up 3% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-3.75% | 9.75M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-36.53% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |
- Stock
- Equities
- Stock Amplia Therapeutics Limited - Australian S.E.
- News Amplia Therapeutics Limited
- Amplia Therapeutics Recruits First Patient for Pancreatic Cancer Clinical Trial